Medicure Inc. (MCUJF) News
Follow Medicure Inc. (MCUJF) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
WINNIPEG, MB / / September 28, 2026 / Medicure Inc. ("Medicure" or the "Company") TSXV:MPHOTC:MCUJF, a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and
NEWS | Sep 28, 2026, 10:01 PM UTC
H
MPH MCUJF - Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
MPH MCUJF - Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
GEOPOLITICS | Sep 08, 2026, 10:25 PM UTC
L
Medicure reports financial results for June 30, 2026 quarter
Medicure reports financial results for the quarter ended June 30, 2026 and schedules an August 17, 2026 conference call.
EARNINGS | Aug 14, 2026, 09:00 PM UTC
L
Medicure Announces CFO Change
WINNIPEG, MB / / July 3, 2026 / Medicure Inc. ("Medicure" or the "Company") (T
EQUITY | Jul 03, 2026, 09:02 PM UTC